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Background: This article reports on the impact assessment experience of a funding program of non-commercial
clinical and health services research. The aim was to assess the level of implementation of results from a subgroup
of research projects (on respiratory diseases), and to detect barriers (or facilitators) in the translation of new
knowledge to informed decision-making.
Methods: A qualitative study was performed. The sample consisted of six projects on respiratory diseases funded
by the Agency for Health Quality and Assessment of Catalonia between 1996 and 2004. Semi-structured interviews to
key informants including researchers and healthcare decision-makers were carried out. Interviews were recorded,
transcribed verbatim and analysed on an individual (key informant) and group (project) basis. In addition, the
differences between achieved and expected impacts were described.
Results: Twenty-three semi-structured interviews were conducted. Most participants indicated changes in health
services or clinical practice had resulted from research. The channels used to transfer new knowledge were mainly
conventional ones, but also in less explicit ways, such as with the involvement of local scientific societies, or via
debates and discussions with colleagues and local leaders. The barriers and facilitators identified were mostly
organizational (in research management, and clinical and healthcare practice), although there were also some
related to the nature of the research as well as personal factors. Both the expected and achieved impacts enabled
the identification of the gaps between what is expected and what is truly achieved.
Conclusions: In this study and according to key informants, the impact of these research projects on decision-
making can be direct (the application of a finding or innovation) or indirect, contributing to a more complex
change in clinical practice and healthcare organization, both having other contextual factors. The channels used to
transfer this new knowledge to clinical practice are complex. Local scientific societies and the relationships between
researchers and decision-makers can play a very important role. Specifically, the relationships between managers
and research teams and the mutual knowledge of their activity have shown to be effective in applying research
funding to practice and decision-making. Finally the facilitating factors and barriers identified by the respondents
are closely related to the idiosyncrasy of the human relations between the different stakeholders involved.
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The importance of understanding research impact and
how research findings are translated into practice or put
into action is widely accepted [1]. However, the know-
ledge translation from research into practice may not be
achieving an optimal exploitation [2-4]. This process
may have low intensity and be unpredictable [5] and
often not dedicated to informing decision-making [6].
The present economic climate and increased competi-
tion for public funds makes this even more critical. In
health sciences, the term “research impact” refers to any
type of output or outcome of research activities which
can be considered a “positive return or payback” for the
scientific community, health systems, patients, and soci-
ety in general [7,8]. Several evaluative frameworks and
methods to capture the returns of health research invest-
ment have been proposed [9].
One of these models, the Return of Investment (ROI),
was developed by the Canadian Academy of Health Sci-
ences (CAHS) [10]. The CAHS-ROI conceptual frame-
work derives from an adaptation of the payback model
from the Brunel University [11,12]. The framework al-
lows the impact of different types of health research
(basic biomedical, applied clinical, health services and
systems, and public population health) to be traced in
five main categories: advancing knowledge, research
capacity-building, informing decision-making, health im-
pact, and broad economic and social impact [13]. Each
category includes a set of impact indicators with ac-
cepted standards of validity and feasibility [14].
The final impact of research, however, will be influenced
by the quality of the research itself and by the extent to
which the knowledge obtained is made available to those
in a position to use it. Therefore, knowledge transfer, its
adoption (adaption), and its application through changes
in behaviour or decision-making creates different inter-
faces among different subjects, mainly between research
producers and knowledge users. The field of implementa-
tion science deals with this transfer which goes beyond
the simple dissemination of knowledge [15]. In the transla-
tion of biomedical research findings it is important to dif-
ferentiate between two main types of transfer: T1 that
deals with the application of new understandings of dis-
ease mechanisms gained in the laboratory into new
methods for diagnosis, therapy, and prevention and their
initial testing in humans and, equally important, T2 refer-
ring to the translation of results from clinical studies into
everyday clinical practice and health decision-making [16].
In the CAHS-ROI model, as in its payback predeces-
sor, the topic of decision-making implicitly includes a
whole array of considerations regarding the model’s
interfaces, the transfer or exchange of knowledge, and
the interrelationship between scientific researchers
and decision-making communities [17]. This is the mostdifficult part to analyse since, in real life, the interrelation-
ship is not linear or unidirectional.
This article is based on the assessment experience of a
funding program of non-commercial clinical and health
services research promoted in Spain by the Agency for
Health Quality and Assessment of Catalonia (hereinafter
the Agency) [18]. The aim of this extramural research
program is not only to fill knowledge gaps but also to
aid decision-makers in the healthcare sector, or, to use
the terminology of the different logic models of impact
assessment, to have an impact on informed decision-
making processes.
The specific aim of the study is to assess the level of
implementation of results from a subgroup of research
projects (dealing with respiratory diseases), based on the
opinion of researchers and a different typology of
healthcare decision-makers as well as to identify the bar-
riers or facilitators of translating new knowledge into in-
formed decision-making. The study also addresses the
multidimensional issue commented by Weiss [19] on the
decision-making process that is differentiating awareness
from implementation and the similarly important aspect
of who takes the role of decision-maker or person in
charge of translating research outputs into daily practice
(implementation).
Methods
A qualitative study with interviews was carried out. It is
an adequate method to explore and understand the per-
ceptions of key informants about a particular social
phenomenon.
Setting and sample
The sample consisted of a subgroup of multicentre pro-
jects on respiratory diseases which were funded between
the 1996 and 2004 by the Agency calls. The topic was
chosen for convenience and its selection was performed
based on pragmatism, feasibility, and accessibility. The
sample had to allow for the analysis of a manageable
number of projects. The selection of projects needed to
include available information and readily accessible key
informants. Only projects completed at the time the
study was performed were included.
Data collection procedures
Semi-structured interviews to key informants and in-
cluded researchers and healthcare decision-makers were
carried out. Clinical group leaders and organizational or
administrative managers in healthcare institutions were
considered to be healthcare decision-makers.
Principal investigators (PIs) of the selected projects
were identified as eligible key respondents. We therefore
identified participants based on their significance. With
regard to healthcare decision-makers, heads of hospital
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agers of centres who participated in the funded research
were identified as potential ‘users’ of project results. The
search for the healthcare decision-makers was made over
the research period of the funded projects and up until
the present. The eligible decision-makers interviewed
needed to be aware of the selected projects, so a screening
questionnaire was used to assess whether they were aware
of these. Following this, snowballing techniques were used
to identify researchers and decision-makers who could
provide the most information regarding the utilisation of
the research. Those who accepted to participate were
contacted to arrange an interview.
The number of participants differed depending on the
number of relevant researchers, decision-makers, and in-
stitutions participating in each project.
The interview guide was developed by our team, for
each group of key informants (researchers and decision-
makers), based on the objectives of the study. The inter-
viewer received prior information and documentation
about the funded projects and their impact assessment
following the framework pattern. The interviews, which
on average lasted between 15 and 30 minutes, were
conducted in a place chosen by the interviewees. Inter-
views were carried out between April and November
2010. The participants in the study were previously in-
formed of the study objectives and the characteristics of
the interview procedure. They were asked to give their
consent for the interviews to be recorded and were en-
sured of confidentiality. In order to maintain anonymity,
every informant interviewed was given a code number
so as to preclude identify them.
The interviews with PIs were semi-structured face-to-
face. They included aspects related to: a) the expected
and use of research results and that achieved in
decision-making in different sectors: clinical, manage-
ment, research, political, etc. (the question addressing the
expected use of results was formulated to identify the pre-
conceived notion that researchers had on what the impact
of the research project ‘should be’; in terms of uses
achieved, the question implicitly attempted to encourage
the researcher to reflect on ‘what really happened’, or what
the achieved impacts were); b) the dissemination of re-
search results; and c) barriers and facilitators in the trans-
lation of research, among others.
For healthcare decision-makers, semi-structured inter-
views were carried out by phone, and the issues covered
included: a) the influence of project results on healthcare
management; b) the implementation of changes; and
c) possible barriers or facilitators for their acceptance.
Data management and analysis
Interviews were recorded and transcribed in full. Data
were analysed using content analysis to select andorganize significant information, to make comparisons be-
tween cases and to identify contradictions and outliers.
Two researchers independently coded data and discussed
this within the multidisciplinary team. This ensured thor-
ough and consistent coding and led to an improvement of
the interpretation of coded themes. Data were analysed on
an individual (key informant) and group (project) basis.
The information was classified according to the changes
which have been induced by research results, in particular,
impact on informed decision-making, the dissemination
of results, and barriers and facilitators to the translation of
research. Moreover, the information was classified as
expected versus achieved use by the levels of the impact
CAHS-ROI model. This analysis consisted of classifying
some of the significant information according to the differ-
ent levels of impact and phases of the CAHS-ROI model
(Figure 1). The aim was to assess the awareness of the
stakeholders involved in the translation of the research re-
sults and the differences between expected impacts and
those achieved. The results obtained from the expected
uses of the projects were then compared with the results
of achieved uses, true changes or implementation, as they
were described by the informants. In order to compare the
utilities detected by the informants in each of the projects
as expected or as achieved, their interactions were
analysed overlapping the different levels of impact with
the phases of the logic model.
Findings were triangulated from different sources
(multiple viewpoints: researchers and decision-makers)
and perspectives (multidisciplinary researchers and dif-
ferent units of analysis: by project and individual).
Results
Of the 109 projects funded and completed, six corre-
sponded to research projects on respiratory diseases. Six-
teen researchers, both principal and outstanding, from 10
healthcare institutions, were contacted and asked to be
interviewed for the study. Of these, 15 agreed to partici-
pate; the others did not participate because they could not
be reached. When a researcher had participated in more
than one project, one interview per project was
performed. Hence, the total number of interviews (n = 19)
was larger than the number of researchers. As for
healthcare decision-makers, 41 people (from seven institu-
tions) were contacted and provided with the questionnaire
inquiring about their knowledge of the research projects.
Of these, 18 replied, 10 of whom declared being aware of
some of the projects on respiratory diseases. Finally, eight
healthcare decision-makers (from four institutions) were
included in the study sample, the other two were ex-
cluded: one because of the impossibility of establishing
contact and the other because the poor recording quality
of the interview. Baseline characteristics of the projects
and the informants are described in Table 1.
Figure 1 Levels of impact and phases of the Canadian Academy of Health Sciences (CAHS-ROI) model.
*Definitions adapted from Panel on the return on investments in health research [14]
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The impact on decision-making was identified mainly at
the intermediate levels of the linear logic model (input-
throughout-primary and secondary output-outcome).
Most participants indicated changes in health services
and/or in clinical practice.
‘New techniques are hard to incorporate, economically
and financially. We had to set up a pneumology day
hospital in order to attend to all the patients who
were being studied, and we did so. And since we had
the day hospital, we took the opportunity to
incorporate other services, and this allowed us to
continue developing this pneumology day hospital’
(decision-maker, P3).These changes were mostly indirectly attributed and
only in one of the projects the attribution was reported
as being direct (P4). Only one of the projects did not re-
sult in any achieved impact because at the time of the
interview only preliminary results were available (P6). In
most of the projects the generation of knowledge or new
research has also been identified as direct consequences
of the project itself, while in only two (P3 and P5), the
economic benefits were stated. Some decision-makers
recognized the importance of the projects in contribut-
ing to an awareness and sensitivity of managers towards
the subject of study (Table 2).
‘The research project made the hospital management
team (manager, general director…) much more
Table 1 Description of the projects and the key informants




P1 - Exacerbation of chronic obstructive pulmonary disease; study of prognostic factors in a cohort of cases 1996-2000 1 PI, 1 I
2 MD, 1 HS
P2 - Study of the risk factors predisposing to acute exacerbation in patients with chronic obstructive
pulmonary disease
1996-1999 1 PI, 5 I
1 MD, 2 HS
P3 - Validation of a diagnostic procedure in the sleep apnea-hypopnea syndrome, based on the clinical
picture and home polysomnography, in the general adult population
1996-1998 1 PI, 2 I
1 MD
P4 - Cost-effectiveness study of home care in exacerbation episodes of chronic obstructive pulmonary
disease by means of the Respiratory-SSIFU (socio-sanitary interdisciplinary functional unit)
1998-2000 3 PI
5 MD
P5 - Strategies for the management of bacterial resistance in the ICU; application of an empirical antibiotic
treatment protocol for ventilation-related pneumonia and impact on the decrease of bacterial resistance
and consumption of antibiotics
2000-2003 1 PI
1 MD
P6 - Phenotypic characterization of chronic obstructive pulmonary disease* 2002-2006 1 PI, 3 I
2 MD, 2 HS
P: project; PI: Principal investigator; I: Relevant investigator; MD: Hospital medical director; HS: Head of hospital service; *This project continued after the Agency
funding ended and therefore only preliminary results were available.
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apnea cycles’ (decision-maker, P3).Dissemination of research results
The diffusion of knowledge was mainly done using con-
ventional means, such as scientific publications and clin-
ical practice guidelines, but also in less explicit ways,
such as via the involvement of local scientific societies,
or in debates and discussions with colleagues and local
leaders (P4). The primary channel of this diffusion as
expressed by the decision-makers were the meetings
held with the research team and/or the heads of
healthcare service involved, and this aspect was readily
expressed when the managers had collaborated directly
in the project (Table 2).
‘…I am aware of them because of proximity to the
researchers involved, not because of their
dissemination…’ (decision-maker, P1, P2, P4 & P6).Barriers and facilitators
Based on the findings, we made a distinction between
internal/external organizational barriers, barriers related
to the nature of research, and cultural and individual
factors. The organizational barriers were related to the
characteristics of the organizational environment and its
management (weak coordination between levels of care,
frequent rotation of general managers). The nature of re-
search barriers referred to factors related to the charac-
teristics of the type of research itself such as difficulties
in the dissemination of results. Finally, cultural and indi-
vidual barriers were related to the attitudes and beliefs
of the researchers (such as resistance to change, or therelationship between the staff who make decisions and
the research team). The results are detailed in Table 3.
Analysis of expected use versus achieved use by levels
of impact
The broad array of impacts achieved was not expected
(unexpected impacts). Also, some expected impacts were
not achieved in the last steps of the model (final out-
comes and adoption phase). Three projects were consid-
ered to have achieved all expected impacts (P1, P3, and
P5). Although impacts were mostly reported on in-
formed decision-making, mostly at an intermediate level
(secondary outputs such as activity in the field of health
or research planning; or in the adoption of results in the
healthcare/delivery services phase), other levels of im-
pact were mentioned by the informants. The impact in
capacity building was described in all but one project
(P6) as an impact that was not expected. Impact in
health benefits and broad economic benefits were also
achieved in some of the projects (P1, P3, and P4), mainly
as final outcomes, while in other cases, these impacts
could not be demonstrated yet (P2 and P4). An example
of the correspondence between impacts expected and
achieved is shown in Figure 2a,b in the cases of project
3 and project 4.
Discussion
This study, based on a specific group of research pro-
jects on respiratory diseases, provides new knowledge on
the perspectives of health researchers and decision-
makers regarding the decision-making process informed
by research findings. Although the study was primarily
aimed at analysing impact on informed decision-making,
impacts on other categories were also identified and
Table 2 Description of the changes induced by the research results and their methods of dissemination mentioned by the key informants
Changes induced by research results
Classification Examples
Changes in health services
and/or clinical practice
Changes in hospital design and management,
such as the creation of a type of service or
contribution to the design of chronic
care services
‘After two years… its home-based hospitalization grew as a real service and an integrated care cross-sectional
unit was created within the hospital.’ (researcher; P4)
Changes in staff management ‘A few years later, that enabled this nurse to become a pneumology case manager nurse. In fact, the only
case manager nurse we have in the Consortium is the pneumology nurse.’ (decision-maker; project 3)
Possible partial contributions to protocols,
guidelines and simplifications of procedures;
for chronic bronchitis patients, for the
treatment and prophylaxis of infections
or sleep studies
‘Yes, indeed, at that time many care protocols were created and in fact with regards to chronic bronchitis patients, the protocols
were based at that time on the criteria that we thought was the most adequate in order to prevent as much as possible
re-exacerbations.’ (researcher; P1)
Identification of modifiable risk factors ‘Yes, some were identified… one of the main results was that physical activity reduced the risk of hospital admission.’
(researcher; P2)
Contribution to the use of an instrument
for the diagnosis of sleep apnea
‘I can’t guarantee that the validation study has been responsible for this dissemination, but I can say that it was
an already validated home process, etc., and it therefore provides some safety, a scientific basis.’ (researcher; P3)
Change in clinical habits ‘Yes, it has all generated a culture… We are essentially a clean unit…’ (researcher; P5).
Impact on healthcare costs In home-based hospitalization ‘The work supported feasibility arguments… it has an economic impact because it reduces costs, it is safe for the
patient, achieves the same results, etc. …’ (researcher; P4)
Procedure simplification ‘This study and other studies that we have conducted have proven that the cost of performing one test
at the hospital equals the cost of performing at least three others at home…’ (researcher; P3).
Generation of new
knowledge
New projects, new studies, new lines ‘… it generated two or three new related projects… at least three projects separate from the PAC COPD
were funded: one on infection, one on inflammation and one on physical activity.’ (researcher; P6)
Dissemination of knowledge
Classification Examples
Scientific publications ‘Presentations at scientific meetings by the research team (it consisted of a team in which several hospitals
participated), presentations at congresses, and publications, of course.’ (researcher; P2)
Direct information to potential users ‘… I think that at the level of clinical sessions … there have been at least three or four sessions that have been important
enough to have an impact within the pneumology service, or at least they have had the highest number of patients.’
(researcher; P6)
Meetings managers - research team ‘We spoke with the head of the internal medicine service and with the pneumology unit head, which is where the doctor
in charge of the project worked, because, in our hospital, these two specialties basically manage the disease.’ (decision-maker)
Participation and/or collaboration of the
decision-maker in the project
‘… because we participated during the time of elaboration, meaning in the meetings prior to starting the project.’ (decision-maker)
Proximity of the decision-maker with
the research team
‘I am aware of them because of proximity to the researchers involved, not because of their dissemination.’ (decision-maker)
Scientific societies ‘It has been highly disseminated in the European Society of Pneumology …, it has resonated significantly in the European
Society of Pneumology, in the American Society of Pneumology, and in the Spanish Society of Pneumology.’ (researcher; P2)
Clinical Practice Guidelines ‘… that is included in the COPD clinical practice guidelines, and has led to a change in the behaviour of physicians.’ (researcher; P2)























Table 3 Description of barriers (facilitators) mentioned by the key informants
Classification of barriers Specific barriers Examples
Organizational barriers/
facilitators
Difficulties in relationships between different
levels of care, or, in other words, the lack of
coordination between them
(non-integrated care)
‘Yes, because we must put primary pharmacologists and hospital specialists on the same wavelength, and so far this
task has not been easy. The primary care professional’s perspective doesn’t exactly match the specialist’s; the latter
has many more nuances, higher costs and clashes with primary care structures.’ (decision-maker; P4)
Lack of institutional involvement ‘It depends on who is involved in the study. If the Catalan Health Service is involved, it should have been willing to offer
recommendations that could have subsequently modified or changed clinical practice guidelines…’ (researcher; P4)
The non-support of clinical managers
and planners
‘The primary care director, the regional management, the primary care division of the Catalan Health Institute and the
Foundation for Primary Care Research (Jordi Gol i Gurina Foundation) granted us their support.’ (researcher; P1)
The frequent changes of managers ‘Because hospital directors and general managers change frequently, or because this issue is not deemed to be as important
as it should be…’ (researcher; P5)
Lack of channels for the translation
of research
‘The main barrier is that there are no well-established channels for the translation of research. And when researchers finish a
study and publish it, there are no other channels, only those created by scientific societies and congresses. This is the main
problem. I also think that there are increasing numbers of tools, such as the Health Plan… the Master Plans, which include
contact with researchers. More tools like these should be strengthened and developed.’ (researcher; P2)
Prioritization of research conducted by
large groups or centres or the limited
opportunities for the promotion of
research in primary care centres
‘I think that healthcare policy is focused on large hospitals and strong research groups, etc., but these clinical aspects of
immediate protection, immediate social repercussion, in which the patient is the beneficiary, are somewhat unattended…’
(researcher; P5)
Previous opportunity in research ‘Having had the opportunity to receive a first grant, for sure. Having started to think at a good time…’ (researcher; P1)
Barriers/facilitator related with
the nature of the research
Difficulties in the dissemination of results due
to interdisciplinary reasons.
‘Clinical journals refused to publish it because they claimed it was too complicated and that clinicians would not understand
it… we preach multidisciplinary research but in practice this is more complicated. You can find economists working with
clinicians and clinicians working with economists, but a clinical article will rarely be included in an economic journal and
vice-versa…’ (researcher, P4).
Lack of interrelationship between research
and industry
‘First, there have been basic initial research projects with first tests, and then it is crucial that industries have manufactured
marketable devices. Therefore, I would say there are two pillars: one, basic research and, the other, the fact that this research
has been carried out by industries.’ (researcher; P3)
Barriers/facilitator derived from
cultural and individual factors
Reluctance to change ‘When the idea of change is raised inside a hospital, in the sense of opening up the hospital, having closer ties with primary
care, performing interventions outside the hospital, etc., it clashes a bit with the culture of doctors and specialists, but overall
when we have carried it out and explained its benefits, we have gotten the approval and participation of many people’
(decision-maker; P4)
The researcher does not self-attribute the role
of disseminating research to managers
‘Overall, I would say that researchers are forced to take on many roles. I am ready to be a researcher, but not to make an
election pamphlet. In this regard, I think the relationship between healthcare policies and health plans is not as it should be.’
(researcher; P6)
Direct participation of the decision-maker
in the project
‘… because we participated during the time of elaboration, meaning in the meetings prior to starting the project’
(decision-maker; P6 and P2)
(No) awareness of decision-makers ‘Directly from the respiratory diseases team I was aware of these projects because I worked in management or in the Drug
Commission, and through some of the commissions I was made aware that the project was going ahead…’
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Figure 2 Impacts expected and achieved, by level of impact and model phase in project 4 (a) and project 3 (b).
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economic benefits). Due to the fact that these levels
were not a part of the study objectives, information
about them might be less complete.
The findings show that the areas of most frequent im-
pact were those at the intermediate level (secondary out-
puts). This is consistent with other studies showing that
the most frequently recognized impact was that in the
areas where the research team had some control and in-
fluence. In other words, impacts are typically found in
the knowledge production, further research orientation,
or in the organizational innovation changes derived from
the project [20,21]. For example, regarding achievedimpact, nearly all of the researchers reported that their
projects have or may have induced changes in clinical
practice or healthcare organization: the changes may
have been few or many, direct or indirect, and attribut-
able to a greater or lesser extent to the corresponding
project. Most of the impacts achieved are beyond the
outputs and even the short-term outcomes in the logic
model, when the project’s influence would have de-
creased to become just an indirect influence [22]. The
approaches used to transfer new knowledge to clinical
and healthcare practice are complex. Local scientific so-
cieties and personal connections between researchers
and local decision-makers seem to play a very important
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search results between peers who share a similar con-
text. This takes place usually before a broader diffusion
via international conference presentation and scientific
publications.
The data obtained have also enabled us to identify spe-
cific aspects that may have favoured or hindered the im-
pact of the projects studied. The facilitators/barriers
identified are much related to the idiosyncrasy of rela-
tionships between the different stakeholders involved.
Specifically, teams that include decision-makers or users
of health information were more effective in achieving
outcomes in health policy or practice from the research
findings. The importance of collaboration between re-
searcher and stakeholders has also grown in recognition
in other studies [23-25]. This also mirrors one of the
conclusions of the study on research impact of the Arth-
ritis Research Campaign, and with one of the recom-
mendations of the CAHS panel that was adopted by
Alberta Innovates Health Solutions (formerly the Alberta
Heritage Foundation for Medical Research) to promote
the inclusion of decision-makers and users in collabora-
tive teams funding programs to promote the transfer of
results between the world of researchers and that of
management. In other words, the fact that 8 out of the
41 contacted healthcare decision-makers who agreed to
be interviewed (prior awareness of at least one of the
projects) have ended up having close relationships (often
prior to the study) with the research team is probably
not coincidental and suggests that it is precisely this re-
lationship or prior joint experience that has facilitated
the dissemination of results, their translation and imple-
mentation. These decision-makers or users of health in-
formation will contribute to or influence the project by
conducting research activities; providing expertise, con-
sultation, and clinical advice; lending the project cred-
ibility and opening the door for additional sources of
funding [26].
Another important facilitator gleaned from the study’s
results is the importance of the interrelationship be-
tween research and industry (for example, in P3). This
factor, raised by the researchers, is very interesting as it
reaffirms the pivotal role of industry in product
innovation. In another study [27] the biggest predictive
factor for the transfer of research to practice and to the
market (after the requirements of regulating bodies are
met) is the industry’s participation in the earliest phases
of research development. Thus, the present study pro-
vides definite examples of organizational, cultural, and
individual barriers to knowledge transfer (such as nega-
tive attitude towards change, unsupportive culture or
mutual mistrust) acknowledged in previous reports
[25,28] while, at the same time, providing further evi-
dence of the facilitator role that the inclusion of keyinformants in research projects [28] may have in such
transfer processes.
The expected impacts and those achieved enabled gaps
between what is expected and what is achieved to be
identified (as shown in Figure 2a,b). The classification
shows that some achieved impacts were not identified as
expected, probably because these were not within the
scope of the project, because the interviewees were not
aware of the impact itself or because they often confused
expected impact with the study’s objective. All this might
reflect a low level of engagement between the re-
searchers and the potential users of their research find-
ings. Similarly, the perception of some researchers was
that they were not responsible for promoting the appli-
cation of their results; meaning, the limited awareness of
some of the stakeholders involved regarding their role as
decision-makers. Moreover, most of the impacts were
achieved in areas within the researchers’ control, such as
in further research, or in secondary outputs. Similarly,
the fact that some expected impacts have not become a
reality could simply be a temporal issue given the recent
completion of the projects, or as a result of the lack of
follow-up studies to identify final outcomes.
The findings of the present study, thus provide some
new information on two critical points of impact gener-
ation: first, they put researcher expectations within the
perspective of actual impact development; and second,
they illustrate some examples of how knowledge is used,
beyond whether it is used, which is recognized as a need
in impact development research [28].
In fact, our findings may point to the need of ex-
panding the components of the CAHS-ROI model,
which has otherwise proved fruitful for our assessment,
by illustrating how the interface between research and
its results and subsequent feedback may not be linear
but rather a complex process depending on several as
yet poorly studied components on which action is pos-
sible (such as personal communication between profes-
sionals or the role of scientific societies). In addition, our
findings show how later types of impact beyond know-
ledge transfer (such as health and economic benefits)
may be gleaned from this interview-based study ap-
proach as done in other studies [29].
With regards to the limitations of the study, the first,
commonly found in this type of studies, consists in the
difficulties of specifying the particular and specific im-
pact of the research project studied and the role that
other studies may have on new knowledge or organi-
zational changes that took place concurrently. It is un-
likely that any of the projects contributed so greatly as
to promote definitive changes in clinical and healthcare
practice, but most did contribute in some apparently un-
deniable way to enriching or improving healthcare prac-
tice. A second limitation would be the time elapsed
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this study was done, which could facilitate the achieve-
ment of impacts in the older studies. However, we found
no big differences between the different projects, probably
because they were related to health services research,
which is intended to translate knowledge into practice at a
much faster rate than other types of research.
Third, the question of whether the conclusions reached
are applicable to other projects is raised. It is obvious that
this is not the case in a study using a convenience sample,
where results can hardly be transferred to other contexts.
However, the study aimed to collect points of view (opin-
ions, judgments, values) that may be indicative or de-
scriptive of similar projects and healthcare setting
characteristics. On the other hand, some strategies were
used to improve validity, such as the triangulation of
sources (different viewpoints) or perspectives (units of
analyses, consensus interpretation with multidisciplinary
researchers) [30]. Moreover, this is an exploratory study
and allows for the generation of new results, which should
be confirmed by the rest of projects granted.
Finally, knowledge of the interaction between the sci-
entific community and the management community
would probably have been better if we had obtained
feedback from other types of healthcare decision-makers,
given that those who were aware of the projects under
study frequently reported having had a relationship with
the research teams prior to the projects, often as a result
of their similar professional profile. This fact probably
facilitated a higher awareness of the results and a greater
participation in improvement initiatives that were dir-
ectly or indirectly related to these results. One could as-
sume that decision-makers who did not respond to the
survey probably had fewer relationships with the
assessed research projects. This result, in spite of its po-
tential relevance in an overall assessment of healthcare
management, was not a study objective. Therefore, there
is still a lot to be learnt, and possibly to be done, in this
field.
Policy implications might apply in some areas. First,
the results proved a number of reasons to advocate for
clinical and health services research funding as a means
to filling knowledge gaps for improved clinical practice,
better healthcare quality, and results. Here one might
argue that promoting this type of research (namely T2
type) [16] to be precise, from the public health depart-
ment or a healthcare organisation that is close to clinical
and health services stakeholders (or individuals with
close relationship), might increase the chances of impact
in improved healthcare services and outcomes. Second,
for relevant research targeting one might argue that
healthcare decision-makers ought to be included in the
research teams. Third, for grant program design and
planning in clinical and health services research someways to improve impacts might be the implementation
of policies to encourage knowledge transfer (or ex-
change) either pushed by the researchers or pulled from
decision-makers.
The findings in the present study do not provide spe-
cific recommendations for policy makers; rather, they
suggest the relevance of researcher/decision maker inter-
action for implementation policies and thus it makes the
case for acknowledging it. As said by other authors [31],
assessing and enhancing evaluation culture may help en-
sure productive research programs: thus, adequate re-
search training and the participation of decision-makers
could represent an effective means for influencing the
way research is used [32].Conclusions
This study provides new knowledge on the perspectives
of researchers and healthcare decision-makers regarding
informed decision-making based on the results of a spe-
cific group of research projects. According to the key in-
formants in this study, the impact of these research
projects on decision-making can be direct (application
of a finding or an innovation) or indirect, contributing
to a complex change in clinical practice or healthcare
organization, together with other contextual factors. The
channels used to transfer this new knowledge to clinical
practice are complex. Local scientific societies and the
relationships between researchers and decision-makers
can play a very important role. Specifically, relationships
between decision-makers and research teams and the
mutual knowledge of their activity have been shown to
be effective in applying the research. Finally the facilitat-
ing factors and barriers identified by the respondents are
closely related to the idiosyncrasy of the relationships
between the different stakeholders involved.
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